summary
Introduced
05/16/2019
05/16/2019
In Committee
05/16/2019
05/16/2019
Crossed Over
Passed
Dead
12/31/2020
12/31/2020
Introduced Session
116th Congress
Bill Summary
A bill to require prescription drug plans and MA-PD plans to report potential fraud, waste, and abuse to the Secretary of Health and Human Services under Medicare part D, and for other purposes. This bill requires prescription drug plan sponsors to report any suspicious activities relating to fraud, waste, or abuse under the Medicare prescription drug benefit and any corrective actions taken.
AI Summary
This bill, the Medicare Prescription Drug Fraud Prevention Act of 2019, requires prescription drug plan sponsors to report any suspicious activities relating to fraud, waste, or abuse under the Medicare prescription drug benefit (Part D) and any corrective actions taken. Specifically, it amends the Social Security Act to mandate that Part D plan sponsors report such activities to the Secretary of Health and Human Services starting on January 1, 2021. The goal is to enhance oversight and address potential fraud, waste, and abuse within the Medicare prescription drug program.
Committee Categories
Budget and Finance
Sponsors (2)
Last Action
Read twice and referred to the Committee on Finance. (on 05/16/2019)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/116th-congress/senate-bill/1505/all-info |
| BillText | https://www.congress.gov/116/bills/s1505/BILLS-116s1505is.pdf |
| Bill | https://www.congress.gov/116/bills/s1505/BILLS-116s1505is.pdf.pdf |
Loading...